Ngā hua rapu - Simone Pieplenbosch
- E whakaatu ana i te 1 - 7 hua o te 7
-
1
Quantitative implications of the updated EARL 2019 PET–CT performance standards mā Andres Kaalep, Coreline N. Burggraaff, Simone Pieplenbosch, Eline E. Verwer, Teréz Séra, Josée M. Zijlstra, Otto S. Hoekstra, Daniela E. Oprea‐Lager, Ronald Boellaard
I whakaputaina 2019Artigo -
2
POS0153 MACROPHAGE [11C]-DPA-713 PET-CT IMAGING TO PREDICT EARLY ANTI-TNF TREATMENT OUTCOME IN RHEUMATOID ARTHRITIS mā W. Van Binsbergen, J. De Jongh, Simone Pieplenbosch, Maqsood Yaqub, Dirkjan van Schaardenburg, Alexandre E. Voskuyl, G. C. J. Zwezerijnen, Conny J. van der Laken
I whakaputaina 2023Artigo -
3
Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma mā Coreline N. Burggraaff, Fareen Rahman, Isabelle Kaßner, Simone Pieplenbosch, Sally F. Barrington, Yvonne W. S. Jauw, Gerben J. C. Zwezerijnen, Stefan Müller, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C. W. de Vet, Ronald Boellaard
I whakaputaina 2020Artigo -
4
First in man study of [18F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis mā N. J. F. Verweij, Maqsood Yaqub, Stefan Bruijnen, Simone Pieplenbosch, Marieke M. ter Wee, Gerrit Jansen, Qingshou Chen, Philip S. Low, Albert D. Windhorst, Adriaan A. Lammertsma, Otto S. Hoekstra, Alexandre E. Voskuyl, Conny J. van der Laken
I whakaputaina 2020Artigo -
5
Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma mā Jakoba J. Eertink, Gerben J. C. Zwezerijnen, Martijn W. Heymans, Simone Pieplenbosch, Sanne E. Wiegers, Ulrich Dührsen, Andreas Hüttmann, Lars Kurch, Christine Hanoun, Pieternella J. Lugtenburg, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Otto S. Hoekstra, Henrica C. W. de Vet, Ronald Boellaard, Josée M. Zijlstra
I whakaputaina 2023Artigo -
6
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients mā Jakoba J. Eertink, C. N. Burggraaff, Martijn W. Heymans, Ulrich Dührsen, Andreas Hüttmann, Christine Hanoun, Stefan Müller, Pieternella J. Lugtenburg, Sally F. Barrington, N. George Mikhaeel, Robert Carr, Sándor Czibor, Tamás Györke, Luca Ceriani, Emanuele Zucca, Martin Hutchings, Lale Kostakoğlu, Annika Loft, Stefano Fanti, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C. W. de Vet
I whakaputaina 2021Artigo -
7
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients mā Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Bart M. de Vries, Pieternella J. Lugtenburg, Sanne E. Wiegers, Gerben J. C. Zwezerijnen, Simone Pieplenbosch, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Henrica C. W. de Vet, Otto S. Hoekstra, Coreline N. Burggraaff, Annelies Bes, Martijn W. Heymans, Yvonne W. S. Jauw, Martine E.D. Chamuleau, Sally F. Barrington, G. Mikhaeel, Emanuele Zucca, Luca Ceriani, Robert Carr, Tamás Györke, Sándor Czibor, Stefano Fanti, Lale Kostakoğlu, Annika Loft, Martin Hutchings, Sze Ting Lee, Josée M. Zijlstra, Ronald Boellaard
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Nuclear medicine
Internal medicine
Diffuse large B-cell lymphoma
Lymphoma
Positron emission tomography
International Prognostic Index
Pathology
Arthritis
Computer science
Economics
Oncology
Radiology
Rheumatoid arthritis
Archaeology
Biochemistry
Biodistribution
Biology
Biotechnology
Cancer
Cancer cell
Chemistry
Chemotherapy
Confidence interval
Cyclophosphamide
Database
Disease
Finance
Folate receptor
Framingham Risk Score